Prophylaxis of mould infections
- PMID: 31475813
- PMCID: PMC6755369
Prophylaxis of mould infections
Abstract
Invasive fungal infection continues to be an important cause of morbidity and mortality in haematological patients. Antifungal prophylaxis in these patients has remarkably increased survival since its introduction. In recent years, new antifungals have been on the rise, being more effective and having less toxicity than previous ones. Nonetheless, the number of patients at risk of fungal infection has also been increasing due to the continuous appearance of new immunosuppressive treatments. As a result of such, we face a changing situation that requires constant updating.
References
-
- Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. . Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50(8):1091–100. doi: 10.1086/651263. - DOI - PubMed
-
- Neofytos D, Chatzis O, Nasioudis D, Boely Janke E, Doco Lecompte T, Garzoni C, et al. . Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study. Transpl Infect Dis. 2018;20(4):e12898. doi: 10.1111/tid.12898. - DOI - PubMed
-
- Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, et al. . The epidemiology of fungal infections in patients with hematologic malignancies: The SEIFEM-2004 study. Haematologica. 2006;91(8):1068–75. PMid: - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials